Product Description
SARS-CoV-2 (COVID-19) S1+S2 ECD (S-ECD), (Wild type,pre-fusion state) Recombinant Protein | 10-122 | ProSci
Tested Application: WB
Application: This recombinant protein can be used for SDS-PAGE.
Tpredicted Molecular Weight: N/A
Physical State: Liquid
Buffer: 20mM Tris,250mM NaCl,0.5%TritonX-100,pH 8.0.
Storage Condition: This product is stable at ≤ -70˚C for up to 1 year from the date of receipt. For optimal storage, aliquot into smaller quantities after centrifugation and store at recommended temperature. Avoid repeated freeze/thaw cycles.
Alternate Name: Cov spike Protein, 2019-nCoV, nCov spike Protein, 2019-nCoV, coronavirus spike Protein, 2019-nCoV, S glycoprotein,COVID-19, S protein, Spike glycoprotein
Background: N/A
Shipping: Dry Ice
Disclaimer: Products are intended for laboratory research purposes only and should be used by qualified personnel only. They are not intended for use in humans. ProSci is not liable for damages or injuries resulting from receipt and/or use of ProSci materials. Please refer to the Material Safety Data Sheet (MSDS) for safe storage, handling, and use procedures.
Source: HEK293 cells
Species: SARS-CoV-2
By Source: Human Cells
By Species: Other
Fusion Tag: His tag at the C-terminus
Sequence: Val11-Gln1208
Bological Activity: Measured by its binding ability in a functional ELISA. Immobilized SARS-CoV-2 S1+S2 ECD (S-ECD) at 2μg/mL (100 μL/well) can bind recombinant Human ACE2 with a linear range of 0.15-3.72 ng/mL
Purity: > 95% by SDS-PAGE.